Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 1/2024

24-02-2023 | Original Paper

Canada population norms for the EQ-5D-5L

Authors: Jiajun Yan, Shitong Xie, Jeffrey A. Johnson, Eleanor Pullenayegum, Arto Ohinmaa, Stirling Bryan, Feng Xie

Published in: The European Journal of Health Economics | Issue 1/2024

Login to get access

Abstract

Objective

In Canada, population norms are only available for 2 provinces, Alberta and Quebec. The objective of this study was to derive the population norms for the EQ-5D-5L based on a representative sample of the Canadian general population.

Methods

Data from the Canadian EQ-5D-5L valuation study, a cross-sectional study, were used. A quota sampling method was used to recruit a representative sample of the Canadian general population in terms of age, sex, and education. EQ-5D-5L utilities and EQ VAS were summarized using descriptive statistics and the impact of demographic characteristics on the EQ-5D-5L utilities was evaluated using statistical hypothesis testing and Tobit regression.

Results

1207 eligible participants were included in the analysis. Pain/discomfort (53.1%) was the most frequently reported domain with any problem, and self-care (7.6%) domain was the least. The mean (standard deviation [SD]) EQ-5D-5L utility was 0.864 (0.121) and the mean (SD) EQ VAS was 82.3 (14.23). The highest mean EQ-5D-5L utility was 0.881 in age group 25–34 while the lowest was 0.839 in age group 55–64. Participants who had full-time employment, were married, a higher annual household income and no chronic health conditions had significantly higher EQ-5D-5L utilities.

Conclusion

This article reports the first Canadian population norms for the EQ-5D-5L and can be used as population references for economic evaluations and clinical research.
Appendix
Available only for authorised users
Literature
1.
Taylor, V.R., Measuring healthy days; population assessment of health-related quality of life (2000)
2.
Stolk, E., et al.: Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health 22(1), 23–30 (2019)PubMedCrossRef
3.
Ramos-Goni, J.M., et al.: Quality control process for EQ-5D-5L valuation studies. Value Health 20(3), 466–473 (2017)PubMedCrossRef
4.
van Hout, B., et al.: Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15(5), 708–715 (2012)PubMedCrossRef
5.
6.
7.
Kennedy-Martin, M., et al.: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur J Health Econ 21(8), 1245–1257 (2020)PubMedPubMedCentralCrossRef
8.
Xie, F., Eleanor, P., Gaebel, K., Bansback, N., Bryan, S., Ohinmaa, A., Poissant, L., Johnson, J.A.: A time trade-off-derived value set of the EQ-5D-5L for Canada. Med. Care 54(1), 98–105 (2016)PubMedCrossRef
9.
Bess, S., et al.: The Health impact of symptomatic adult spinal deformity: comparison of deformity types to United States Population Norms and Chronic Diseases. Spine (Phila Pa 1976) 41(3), 224–233 (2016)PubMedCrossRef
10.
Sutherland, H.J., Fyles, G.M., Adams, G., Hao, Y., Lipton, J.H., Minden, M.D., Meharchand, J.M., Tejpar, I., Messner, H.A., Atkins, H.: Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transpl 19, 1129–1136 (1997)CrossRef
11.
12.
Hawkins, K.A., Bender, S.: Norms and the relationship of Boston naming test performance to vocabulary and education: a review. Aphasiology 16(12), 1143–1153 (2002)CrossRef
13.
Team, T.A., Alberta Population Norms for EQ-5D-5L: Alberta PROMs & EQ-5D Research & Support Unit (APERSU). School of Public Health, University of Alberta (2018)
14.
Poder, T.G., Carrier, N., Kouakou, C.R.C.: Quebec health-related quality-of-life population norms using the EQ-5D-5L: decomposition by sociodemographic data and health problems. Value Health 23(2), 251–259 (2020)PubMedCrossRef
15.
Azzi, J., et al.: PNS261 EQ-5D-5L in France, Germany and Spain: Population Norms and Comparison between the Countries. Value in Health 23, S685 (2020)CrossRef
16.
Bailey, H., et al.: EQ-5D self-reported health in Barbados and Jamaica with EQ-5D-5L population norms for the English-speaking Caribbean. Health Qual. Life Outcomes 19(1), 97 (2021)PubMedPubMedCentralCrossRef
17.
Bailey, H., et al.: Health-related quality of life population norms for Belize using EQ-5D-5L. Value Health Reg. Issues 29, 45–52 (2022)PubMedCrossRef
18.
19.
Cesana, L.S.P.A.C.R.C.G. and L.G. Mantovani, health related quality of life norm data of the general population in Italy: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiology Biostatistics and Public Health 12(3), (2015
20.
Emrani, Z., et al.: Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran. Health Qual. Life Outcomes 18(1), 108 (2020)PubMedPubMedCentralCrossRef
21.
Encheva, M., et al.: EQ-5D-5L Bulgarian population norms. Eur. J. Health Econ 21(8), 1169–1178 (2020)PubMedCrossRef
22.
Garcia-Gordillo, M.A., Adsuar, J.C., Olivares, P.R.: Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011. Qual Life Res 25(5), 1313–1321 (2016)PubMedCrossRef
23.
Garratt, A.M., et al.: Norwegian population norms for the EQ-5D-5L: results from a general population survey. Qual Life Res 31(2), 517–526 (2022)PubMedCrossRef
24.
25.
Hernandez, G., et al.: Validity of the EQ-5D-5L and reference norms for the Spanish population. Qual Life Res 27(9), 2337–2348 (2018)PubMedCrossRef
26.
Hobbins, A., et al.: The health of the residents of Ireland: Population norms for Ireland based on the EQ-5D-5L descriptive system - a cross sectional study. HRB Open Res 1, 22 (2018)PubMedPubMedCentralCrossRef
27.
28.
Jiang, R., Janssen, M.F.B., Pickard, A.S.: US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Qual Life Res 30(3), 803–816 (2021)PubMedCrossRef
29.
30.
McCaffrey, N., et al.: Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual. Life Outcomes 14(1), 133 (2016)PubMedPubMedCentralCrossRef
31.
32.
33.
Purba, F.D., et al.: Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS ONE 13(5), e0197098 (2018)PubMedPubMedCentralCrossRef
34.
Shiroiwa, T., et al.: Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual. Life Res 25(3), 707–719 (2016)PubMedCrossRef
35.
Sullivan, T., et al.: New Zealand population norms for the EQ-5D-5L constructed from the personal value sets of participants in a national survey. Value Health 24(9), 1308–1318 (2021)PubMedCrossRef
36.
Van Wilder, L., et al.: Belgian population norms for the EQ-5D-5L, 2018. Qual. Life Res 31(2), 527–537 (2022)PubMedCrossRef
37.
Wong, E.L., et al.: Normative profile of health-related quality of life for Hong Kong general population using preference-based instrument EQ-5D-5L. Value Health 22(8), 916–924 (2019)PubMedCrossRef
38.
Xie, S., Wu, J., Xie, F.: Population Norms for SF-6Dv2 and EQ-5D-5L in China. Appl Health Econ Health Policy 20, 573–585 (2022)PubMedCrossRef
39.
40.
Bailey, H.H., et al.: EQ-5D-5L population norms and health inequality in Colombia. Value Health Reg Issues 26, 24–32 (2021)PubMedCrossRef
41.
Oppe, M., et al.: A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health 17(4), 445–453 (2014)PubMedCrossRef
42.
R Core Team R: A language and environment for statistical computing. Foundation for Statistical Computing, Vienna, Austria (2022)
43.
Yee, T.W., Hadi, A.F.: Row-column interaction models, with an R implementation. Comput. Stat. 29(6), 1427–1445 (2014)CrossRef
44.
Yee, T.W., Stoklisa, J., Huggins, R.M.: The VGAM package for capture-recapture data using the conditional likelihood. J. Stat. Softw. 65(5), 1–33 (2015)CrossRef
45.
Yee, T.W., Wild, C.J.: Vector generalized additive models. J. R. Stat. Soc. Ser. B 58(3), 481–493 (1996)
46.
Yee, T.W.: Vector generalized linear and additive models: with an implementation in R. Springer, New york (2015)CrossRef
47.
Yee, T.W.: The VGAM package for categorical data analysis. J. Stat. Softw. 32(10), 1–34 (2010)CrossRef
48.
Yee, T.W.: VGAM: vector generalized linear and additive models R package version 1.0–5 (2018)
49.
Yee, T.W.: Two-parameter reduced-rank vector generalized linear models. Comput. Stat. Data Anal. 71, 889–902 (2013)CrossRef
50.
51.
Holownia-Voloskova, M., Tarbastaev, A., Golicki, D.: Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey. Qual. Life Res. 30(3), 831–840 (2021)PubMedCrossRef
52.
Pickard, A.S., Neary, M.P., Cella, D.: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual. Life Outcomes 5, 70 (2007)PubMedPubMedCentralCrossRef
53.
Tsai, A.P.Y., et al.: Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax 76(1), 37–43 (2021)PubMedCrossRef
Metadata
Title
Canada population norms for the EQ-5D-5L
Authors
Jiajun Yan
Shitong Xie
Jeffrey A. Johnson
Eleanor Pullenayegum
Arto Ohinmaa
Stirling Bryan
Feng Xie
Publication date
24-02-2023
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 1/2024
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-023-01570-1

Other articles of this Issue 1/2024

The European Journal of Health Economics 1/2024 Go to the issue

Correction

Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic

Editorial

Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality

Original Paper

Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data

Original Paper

Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population

Original Paper

Risk, time preferences, trustworthiness and COVID-19 preventive behavior: evidence from France

Original Paper

Health-related quality of life assessed by EQ-5D-5L and its determinants among rural adults: result from the Henan rural cohort study